FI914607A0 - Farmaceutisk blandning i gelform i en dispenserfoerpackning. - Google Patents

Farmaceutisk blandning i gelform i en dispenserfoerpackning.

Info

Publication number
FI914607A0
FI914607A0 FI914607A FI914607A FI914607A0 FI 914607 A0 FI914607 A0 FI 914607A0 FI 914607 A FI914607 A FI 914607A FI 914607 A FI914607 A FI 914607A FI 914607 A0 FI914607 A0 FI 914607A0
Authority
FI
Finland
Prior art keywords
pharmaceutical
dispenserfoerpackning
gelform
blanding
composition
Prior art date
Application number
FI914607A
Other languages
English (en)
Other versions
FI914607A (fi
FI104947B (fi
Inventor
Pierre Tachon
Beatrice Vagneur
Jean-Louis Viret
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of FI914607A0 publication Critical patent/FI914607A0/fi
Publication of FI914607A publication Critical patent/FI914607A/fi
Application granted granted Critical
Publication of FI104947B publication Critical patent/FI104947B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Emergency Medicine (AREA)
  • Physiology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • External Artificial Organs (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
FI914607A 1990-10-04 1991-10-01 Menetelmä pakatun farmaseuttisen seoksen valmistamiseksi FI104947B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP90118920 1990-10-04
EP90118920 1990-10-04

Publications (3)

Publication Number Publication Date
FI914607A0 true FI914607A0 (fi) 1991-10-01
FI914607A FI914607A (fi) 1992-04-05
FI104947B FI104947B (fi) 2000-05-15

Family

ID=8204572

Family Applications (1)

Application Number Title Priority Date Filing Date
FI914607A FI104947B (fi) 1990-10-04 1991-10-01 Menetelmä pakatun farmaseuttisen seoksen valmistamiseksi

Country Status (27)

Country Link
US (2) US5300302A (fi)
EP (1) EP0479005B1 (fi)
JP (1) JP3219799B2 (fi)
KR (1) KR100213513B1 (fi)
AT (1) ATE131039T1 (fi)
AU (1) AU643067B2 (fi)
BR (1) BR9104280A (fi)
CA (1) CA2052615C (fi)
DE (1) DE69115210T2 (fi)
DK (1) DK0479005T3 (fi)
DZ (1) DZ1530A1 (fi)
EG (1) EG19906A (fi)
ES (1) ES2081407T3 (fi)
FI (1) FI104947B (fi)
GR (1) GR3018893T3 (fi)
HU (1) HU219222B (fi)
IE (1) IE72146B1 (fi)
IL (1) IL99509A (fi)
MA (1) MA22289A1 (fi)
MX (1) MX9101391A (fi)
MY (1) MY107488A (fi)
NO (1) NO303525B1 (fi)
NZ (1) NZ240068A (fi)
PT (1) PT99143B (fi)
RU (1) RU2093143C1 (fi)
TN (1) TNSN91085A1 (fi)
ZA (1) ZA917627B (fi)

Families Citing this family (101)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5300302A (en) * 1990-10-04 1994-04-05 Nestec S.A. Pharmaceutical composition in gel form in a dispensing package
MX9304638A (es) * 1992-07-31 1994-05-31 Neose Pharm Inc Composicion para tratar e inhibir las ulceras gastricas y duodenales.
JPH06172189A (ja) * 1992-08-17 1994-06-21 Bristol Myers Squibb Co 胃腸保護複合剤
US5881926A (en) * 1993-03-11 1999-03-16 Taro Pharmaceutical Industries, Ltd. Pharmaceutical compositions in semisolid form and a device for administration thereof
IL108366A (en) * 1993-03-11 1999-11-30 Taro Vit Ind Ltd Semi-solid pharmaceutical compounds and a device for their use
WO1996011162A1 (en) * 1994-10-11 1996-04-18 Monson James A Dispensing apparatus for foaming compositions and method
US5976573A (en) * 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
ATE197900T1 (de) * 1996-08-15 2000-12-15 Losan Pharma Gmbh Gut schluckbare orale arzneiform
US5759579A (en) * 1996-12-05 1998-06-02 American Home Products Corporation Pharmaceutical suspension systems
GB9720061D0 (en) 1997-09-19 1997-11-19 Crosfield Joseph & Sons Metal compounds as phosphate binders
US6071523A (en) 1998-06-03 2000-06-06 Taro Pharmaceuticals Industries, Ltd. Spill resistant pharmaceutical compositions in semi-solid form
US7919109B2 (en) 1999-02-08 2011-04-05 Intarcia Therapeutics, Inc. Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
US7258869B1 (en) * 1999-02-08 2007-08-21 Alza Corporation Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
KR100399483B1 (ko) * 2000-12-12 2003-09-29 대화제약 주식회사 플로로글루시놀을 유효성분으로 함유하는 신규 진경액제
EA006777B1 (ru) * 2001-06-22 2006-04-28 Пфайзер Продактс Инк. Фармацевтические композиции адсорбатов аморфного лекарственного средства
EP1411899B1 (en) * 2001-08-01 2009-03-11 Novartis AG Taste masking composition
US7638150B2 (en) * 2002-08-02 2009-12-29 Simply Thick Llp Process for preparing concentrate thickener compositions
US20030068375A1 (en) 2001-08-06 2003-04-10 Curtis Wright Pharmaceutical formulation containing gelling agent
IL161500A0 (en) * 2001-10-22 2004-09-27 Taro Pharma Ind Taste masking spill-resistant formulation
US20030235618A1 (en) * 2001-10-22 2003-12-25 Taro Pharmaceutical Industries Ltd. Taste masking spill-resistant formulation
US20050143471A1 (en) * 2001-10-22 2005-06-30 Shen Gao Taste masking spill-resistant formulation
CA2467245A1 (en) * 2001-12-06 2003-06-19 Duke University Prevention of flap necrosis in plastic surgery
WO2003063833A1 (en) * 2002-02-01 2003-08-07 Pfizer Products Inc. Pharmaceutical compositions of amorphous dispersions of drugs and lipophilic microphase-forming materials
US20030166732A1 (en) * 2002-02-27 2003-09-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol for the treatment of painful conditions in the mouth and pharyngeal cavity
US20040258716A1 (en) * 2002-06-17 2004-12-23 Shen Gao Ibuprofen suspension
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
CA2694872A1 (en) * 2003-01-31 2004-08-19 Simply Thick Llc Improved thickened beverages for dysphagia
BRPI0413277A (pt) 2003-08-04 2006-10-10 Pfizer Prod Inc composições farmacêuticas de adsorvatos de medicamentos amorfos e materiais que formam microfases lipofìlicas
US7201920B2 (en) * 2003-11-26 2007-04-10 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse of opioid containing dosage forms
US20080255104A1 (en) * 2004-05-04 2008-10-16 Equitech Corporation Nsaid Compositions
ES2653568T3 (es) 2004-06-12 2018-02-07 Collegium Pharmaceutical, Inc. Formulaciones de fármacos para la prevención del abuso
AU2005309586A1 (en) * 2004-11-24 2006-06-01 Algorx Pharmaceuticals, Inc. Capsaicinoid gel formulation and uses thereof
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
US8532938B2 (en) * 2005-11-17 2013-09-10 The Invention Science Fund I, Llc Testing-dependent administration of a nutraceutical
US20070112589A1 (en) * 2005-11-17 2007-05-17 Searete Llc, A Limited Liability Corporation Of The State Of Delaware User interface for providing assistance related to health
US20070119928A1 (en) * 2005-11-17 2007-05-31 Jung Edward K Generating a nutraceutical request from an inventory
US10042980B2 (en) * 2005-11-17 2018-08-07 Gearbox Llc Providing assistance related to health
US20070112592A1 (en) * 2005-11-17 2007-05-17 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Payments in providing assistance related to health
US8468029B2 (en) * 2005-11-17 2013-06-18 The Invention Science Fund I, Llc Subscriptions for assistance related to health
US20080193919A1 (en) * 2005-11-30 2008-08-14 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Systems and methods for receiving pathogen related information and responding
US8340944B2 (en) * 2005-11-30 2012-12-25 The Invention Science Fund I, Llc Computational and/or control systems and methods related to nutraceutical agent selection and dosing
US20080082272A1 (en) * 2005-11-30 2008-04-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems and methods related to nutraceuticals
US7927787B2 (en) 2006-06-28 2011-04-19 The Invention Science Fund I, Llc Methods and systems for analysis of nutraceutical associated components
US8000981B2 (en) * 2005-11-30 2011-08-16 The Invention Science Fund I, Llc Methods and systems related to receiving nutraceutical associated information
US10296720B2 (en) * 2005-11-30 2019-05-21 Gearbox Llc Computational systems and methods related to nutraceuticals
US20070289258A1 (en) * 2006-06-14 2007-12-20 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Individualized pharmaceutical selection and packaging
US20070136092A1 (en) * 2005-11-30 2007-06-14 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems related to individualized pharmaceutical and nutraceutical selection and packaging
US20080052114A1 (en) * 2005-11-30 2008-02-28 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems and methods related to nutraceuticals
US20080210748A1 (en) * 2005-11-30 2008-09-04 Searete Llc, A Limited Liability Corporation Of The State Of Delaware, Systems and methods for receiving pathogen related information and responding
US20110145009A1 (en) * 2005-11-30 2011-06-16 Jung Edward K Y Methods and systems related to transmission of nutraceutical associatd information
US20080004909A1 (en) * 2005-11-30 2008-01-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems related to nutraceuticals
US20070124219A1 (en) * 2005-11-30 2007-05-31 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems related to individualized nutraceutical selection and packaging
US7974856B2 (en) * 2005-11-30 2011-07-05 The Invention Science Fund I, Llc Computational systems and methods related to nutraceuticals
US7827042B2 (en) * 2005-11-30 2010-11-02 The Invention Science Fund I, Inc Methods and systems related to transmission of nutraceutical associated information
US20080004905A1 (en) * 2006-06-28 2008-01-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for analysis of nutraceutical associated components
US20080033763A1 (en) * 2005-11-30 2008-02-07 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems related to receiving nutraceutical associated information
US8297028B2 (en) * 2006-06-14 2012-10-30 The Invention Science Fund I, Llc Individualized pharmaceutical selection and packaging
US20070174128A1 (en) * 2005-11-30 2007-07-26 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems related to individualized pharmaceutical and nutraceutical selection and packaging
US20080114577A1 (en) * 2005-11-30 2008-05-15 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational methods and systems associated with nutraceutical related assays
US20070124176A1 (en) * 2005-11-30 2007-05-31 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems and methods related to nutraceutical agent selection and dosing
WO2007075378A2 (en) * 2005-12-20 2007-07-05 Searete Llc Control systems for individualized pharmaceutical and nutraceutical selection and packaging
MY157620A (en) 2006-01-31 2016-06-30 Cytochroma Dev Inc A granular material of a solid water-soluble mixed metal compound capable of binding phosphate
ES2351527T3 (es) 2006-05-30 2011-02-07 Intarcia Therapeutics, Inc Modulador de flujo en dos piezas con conducto interno para un sistema osmótico de administración.
US20080086339A1 (en) * 2006-06-23 2008-04-10 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Customized visual marking for medication labeling
US20070299695A1 (en) * 2006-06-23 2007-12-27 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Customized visual marking for medication labeling
US20080086338A1 (en) * 2006-06-23 2008-04-10 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Customized visual marking for medication labeling
PL2359808T3 (pl) 2006-08-09 2013-10-31 Intarcia Therapeutics Inc Osmotyczne systemy dostawcze i zespoły tłokowe
KR20080076667A (ko) 2007-02-15 2008-08-20 주식회사 중외제약 요변성 약학 조성물
AU2008244523B2 (en) 2007-04-23 2012-02-16 Intarcia Therapeutics, Inc. Suspension formulations of insulinotropic peptides and uses thereof
EP2152095B1 (en) * 2007-05-07 2012-08-29 Precision Foods, Inc Food thickening agent, method for producing food thickening agent
US8001345B2 (en) * 2007-05-10 2011-08-16 Dot Hill Systems Corporation Automatic triggering of backing store re-initialization
US8968786B2 (en) 2007-06-22 2015-03-03 Board Of Regents, The University Of Texas System Formation of stable submicron peptide or protein particles by thin film freezing
GB0714670D0 (en) * 2007-07-27 2007-09-05 Ineos Healthcare Ltd Use
GB0720220D0 (en) * 2007-10-16 2007-11-28 Ineos Healthcare Ltd Compound
WO2009102467A2 (en) 2008-02-13 2009-08-20 Intarcia Therapeutics, Inc. Devices, formulations, and methods for delivery of multiple beneficial agents
GB0818473D0 (en) 2008-10-08 2008-11-12 Probio Nutraceuticals As Composition
KR20110103961A (ko) 2008-11-16 2011-09-21 보드 오브 리전츠 더 유니버시티 오브 텍사스 시스템 저점도 고농축 현탁액
US9795617B2 (en) 2009-06-18 2017-10-24 Baucom Institute for Longevity and Life Enhancement, Inc. Hormone delivery system and method
US8658628B2 (en) * 2009-06-18 2014-02-25 Karan Y. Baucom Hormone delivery system and method
GB0913525D0 (en) 2009-08-03 2009-09-16 Ineos Healthcare Ltd Method
KR102093612B1 (ko) 2009-09-28 2020-03-26 인타르시아 세라퓨틱스 인코포레이티드 실질 항정상태 약물 전달의 신속 확립 및/또는 종결
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
GB201001779D0 (en) 2010-02-04 2010-03-24 Ineos Healthcare Ltd Composition
LT2826467T (lt) 2010-12-22 2017-09-25 Purdue Pharma L.P. Padidinto saugumo kontroliuojamo atpalaidavimo vaisto forma
EP2654733B1 (en) 2010-12-23 2016-04-06 Purdue Pharma LP Tamper resistant solid oral dosage forms
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
HUE040129T2 (hu) * 2011-12-22 2019-02-28 Babolna Bio Ltd Elfogyasztható vizes gél kártevõirtásban való alkalmazásra, vizes gélt tartalmazó kártevõirtó eszköz és vizes gél alkalmazása kártevõirtó eszközben és kártevõirtó eljárásban
US20150290131A1 (en) * 2012-10-25 2015-10-15 Nestec S.A. Encapsulated bitter peptides, methods of encapsulating bitter peptides, and nutritional compositions including encapsulated bitter peptides
US8550131B1 (en) 2013-01-02 2013-10-08 Liquid Squeeze, LLC Liquid dispensing device, system and method
US10751287B2 (en) 2013-03-15 2020-08-25 Purdue Pharma L.P. Tamper resistant pharmaceutical formulations
US9101156B2 (en) 2013-03-15 2015-08-11 Kent Precision Foods Group, Inc. Thickener composition, thickened nutritive products, methods for preparing thickened nutritive products, and methods for providing nutrition
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
KR20240042548A (ko) 2015-06-03 2024-04-02 인타르시아 세라퓨틱스 인코포레이티드 임플란트 배치 및 제거 시스템들
PL3319596T3 (pl) * 2015-07-09 2024-04-15 Uniwell Laboratories Llc Farmaceutyczne kompozycje
TWI814219B (zh) 2016-05-16 2023-09-01 美商因塔希亞治療公司 升糖素受體選擇性多肽和彼之使用方法
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
US9737530B1 (en) 2016-06-23 2017-08-22 Collegium Pharmaceutical, Inc. Process of making stable abuse-deterrent oral formulations
IL267736B2 (en) 2017-01-03 2024-03-01 Intarcia Therapeutics Inc Methods involving continuous administration of a GLP-1 receptor agonist and co-administration of a drug
US11751594B2 (en) 2020-10-22 2023-09-12 Grain Processing Corporation Food thickener composition and method

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3767784A (en) * 1970-12-01 1973-10-23 S Gluck Composition for the protection and treatment of injured body tissue and method of utilizing the same
US4155741A (en) * 1974-05-01 1979-05-22 Stauffer Chemical Company Stable suspension system for microencapsulated flowable formulations, and method of preparing stable suspension of microcapsules
US4136177A (en) * 1977-01-31 1979-01-23 American Home Products Corp. Xanthan gum therapeutic compositions
US4305933A (en) * 1980-03-10 1981-12-15 Wiczer Sol B Thickened gelatinous edible alcoholic medicated carrier
US4424055A (en) * 1981-12-18 1984-01-03 Herman Wesley K Irrigation and aspiration syringe
US4427681A (en) * 1982-09-16 1984-01-24 Richardson-Vicks, Inc. Thixotropic compositions easily convertible to pourable liquids
USRE32969E (en) * 1982-10-14 1989-06-27 Injectionable visoelastic ophthalmic gel
US4576645A (en) * 1984-12-06 1986-03-18 Block Drug Co., Inc. Whipped gel composition
IT1183574B (it) * 1985-05-08 1987-10-22 Eurand Spa Metodo per ottenere una sospensione estemporanea omogenea di microcapsule
US4708834A (en) * 1986-05-01 1987-11-24 Pharmacaps, Inc. Preparation of gelatin-encapsulated controlled release composition
IT1234194B (it) * 1988-05-31 1992-05-06 Magis Farmaceutici Composizioni farmaceutiche in forma di sciroppo contenenti pentitoli quali agenti di veicolazione
US5288479A (en) * 1989-01-17 1994-02-22 Sterling Drug, Inc. Extrudable elastic oral pharmaceutical gel compositions and metered dose dispensers containing them and method of making and method of use thereof
US5215739A (en) * 1989-04-05 1993-06-01 Toko Yakuhin Kogyo Kabushiki Kaisha Spray gel base and spray gel preparation using thereof
US4994277A (en) * 1989-10-31 1991-02-19 Pfizer Hospital Products Group, Inc. Use of xanthan gum for preventing adhesions
US5300302A (en) * 1990-10-04 1994-04-05 Nestec S.A. Pharmaceutical composition in gel form in a dispensing package

Also Published As

Publication number Publication date
MX9101391A (es) 1992-04-01
MA22289A1 (fr) 1992-04-01
KR100213513B1 (ko) 1999-08-02
ZA917627B (en) 1992-06-24
EP0479005A1 (fr) 1992-04-08
US5300302A (en) 1994-04-05
BR9104280A (pt) 1992-06-02
DK0479005T3 (da) 1996-03-11
HUT59587A (en) 1992-06-29
NO913847D0 (no) 1991-10-01
DE69115210T2 (de) 1996-05-09
NO913847L (no) 1992-04-06
CA2052615A1 (en) 1992-04-05
GR3018893T3 (en) 1996-05-31
IE72146B1 (en) 1997-03-26
HU912990D0 (en) 1992-01-28
DE69115210D1 (de) 1996-01-18
JPH04247023A (ja) 1992-09-03
ES2081407T3 (es) 1996-03-01
NO303525B1 (no) 1998-07-27
EG19906A (fr) 1996-05-31
RU2093143C1 (ru) 1997-10-20
NZ240068A (en) 1994-05-26
AU643067B2 (en) 1993-11-04
AU8458991A (en) 1992-04-09
MY107488A (en) 1995-12-30
JP3219799B2 (ja) 2001-10-15
PT99143B (pt) 1999-04-30
EP0479005B1 (fr) 1995-12-06
PT99143A (pt) 1993-12-31
KR920007621A (ko) 1992-05-27
FI914607A (fi) 1992-04-05
DZ1530A1 (fr) 2002-02-17
ATE131039T1 (de) 1995-12-15
HU219222B (en) 2001-03-28
TNSN91085A1 (fr) 1992-10-25
IL99509A (en) 1995-08-31
US5505959A (en) 1996-04-09
CA2052615C (en) 2001-01-16
IE913286A1 (en) 1992-04-08
FI104947B (fi) 2000-05-15
IL99509A0 (en) 1992-08-18

Similar Documents

Publication Publication Date Title
FI914607A (fi) Farmaceutisk blandning i gelform i en dispenserfoerpackning.
HK1012556A1 (en) Preserved ophthalmic drug compositions containing polymeric quaternary ammonium compounds
IT8947938A0 (it) Adsorbati di resina, procedimento per prepararli e composizioni farmaceutiche che li contengono
MX9600857A (es) Forma de dosificacion i en tabletas, con unidades multiples.
SE7714066L (sv) Tillforselenhet for biologiskt aktiva emnen
FI955215A (fi) Hallitusti vapauttavat oksibutyniinivalmisteet
DE69432025T2 (de) Formulierungen mit verzögerter freisetzung zur abgabe von metoprolol über 24 stunden
FI961437A0 (fi) Vaikuttavan aineen luovuttava systeemi
ITRM910402A0 (it) Articolo contenente medicamento e dispositivo di erogazione per esso.
NO882897L (no) Avleveringssystem for legemidler.
DK0457849T3 (da) Klæbemiddel til elektrotransport
FI963515A (fi) Laastarin muodossa oleva transdermaalinen systeemi, joka sisältää tamoksifeenijohdosta
ZA902066B (en) Solid gel external drug delivery system
IT1243193B (it) Composizioni farmaceutiche orali a base di melatonina
DE59510583D1 (de) Pharmazeutische zusammensetzung zur systemischen transdermalen verabreichung mit dem wirkstoff morphin-6-glucuronid
DE59607949D1 (de) Feste arzneimittelform mit polymerem material verteiltem wirkstoff
EP0595226A3 (en) Active substance-containing polymer gel
ES8704903A1 (es) Un metodo para preparar 6-cloro-2-metil-1h-2,3,4,5-tetrahidro-3-benzazepen-n-oxido.
IT1283324B1 (it) Composizioni veterinarie a base di antibatterici per uso intramammario
EP0408019A3 (en) Pharmaceutical active derivative delivery systems
IT8322815A0 (it) Formulazioni farmaceutiche adattivita' antisettica.